FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.

Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

The diet, which is rich in fats and low in carbohydrates, may help alter how your body manages and utilises energy, ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

inhibitors — these help a person’s pancreas produce more insulin and less glucagon, to reduce their blood glucose levels glucagon-like peptide-1 (GLP-1) receptor agonists — these stimulate insulin ...

The nonclinical pharmacokinetic (PK) and pharmacodynamic (PD) study was conducted to examine the effects of semaglutide ...

If the person with diabetes is unconscious or you don't know how to use glucagon, call 911. People with diabetes who take insulin should have a prescription for either injectable glucagon or inhaled ...

It is typically prescribed when insulin alone does not control blood sugar well enough. Symlin works just like the naturally occurring amylin to lower blood sugar in three ways: Lowers glucagon ...

Insulin attaches to the glucose molecules and carries them to your cells, which use the glucose for energy. Glucagon is another hormone that has the opposite effect of insulin. When you go without ...

Glucagon, a key hormone in the regulation of glucose homeostasis, acts as a counter-regulatory hormone to insulin by promoting hepatic glucose output. Under normal conditions, insulin and glucagon ...

Results: The splanchnic bed released GDF15 to the circulation during exercise and increasing the glucagon-to-insulin ratio in resting humans led to a 2.7-fold (P<0.05) increase in circulating GDF15.